– Bloomberg
Mixed Sentiment Persists Amid Uncertainty in QuidelOrtho’s Core Profitability: Analyst
QuidelOrtho Corporation (NASDAQ: QDEL) released preliminary Q3 revenue of $738 million to $744 million, primarily driven by higher respiratory product sales,